Leukemia Clinical Trials in Incheon
3 recruitingIncheon, South Korea
Showing 1–3 of 3 trials
Recruiting
Phase 3
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Leukemia
Daiichi Sankyo700 enrolled292 locationsNCT06578247
Recruiting
Phase 2
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Acute Myeloid LeukemiaLeukemia
Daiichi Sankyo130 enrolled58 locationsNCT06824168
Recruiting
Asciminib RMP Study
Chronic Myeloid Leukemia
Novartis Pharmaceuticals100 enrolled14 locationsNCT05943522